Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23710330)

1.

Lung transplantation.

Meyer KC.

F1000Prime Rep. 2013 May 1;5:16. doi: 10.12703/P5-16. Print 2013.

2.

Updates in lung transplantation.

Zamora MR.

Clin Transpl. 2012:185-92. Review.

PMID:
23721021
3.

Extracorporeal photophoresis: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(6):1-82. Epub 2006 Mar 1.

4.

Optimizing post-transplant outcomes in lung transplantation.

McCartney JG, Meyer KC.

Expert Rev Respir Med. 2008 Apr;2(2):183-99. doi: 10.1586/17476348.2.2.183.

PMID:
20477248
5.

Contemporary lung transplantation: the UCLA experience.

Sherman W, Rabkin D, Ross D, Ardehali A; UCLA Lung Transplant Program.

Clin Transpl. 2008:163-70.

PMID:
19708455
6.

Chronic lung allograft dysfunction after lung transplantation: the moving target.

Sato M.

Gen Thorac Cardiovasc Surg. 2013 Feb;61(2):67-78. doi: 10.1007/s11748-012-0167-3. Epub 2012 Nov 10. Review.

PMID:
23138970
7.

A new classification system for chronic lung allograft dysfunction.

Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P.

J Heart Lung Transplant. 2014 Feb;33(2):127-33. doi: 10.1016/j.healun.2013.10.022. Epub 2013 Oct 24.

PMID:
24374027
8.

Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.

Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, Keshavjee S.

J Heart Lung Transplant. 2011 Jul;30(7):735-42. doi: 10.1016/j.healun.2011.01.712. Epub 2011 Mar 17.

PMID:
21419659
10.

Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?

Snell GI, Paraskeva M, Westall GP.

Paediatr Drugs. 2013 Aug;15(4):281-9. doi: 10.1007/s40272-013-0026-4.

PMID:
23605986
11.

Are we near to an effective drug treatment for bronchiolitis obliterans?

Verleden GM, Vos R, Dupont L, Van Raemdonck DE, Vanaudenaerde BM, Verleden SE.

Expert Opin Pharmacother. 2014 Oct;15(15):2117-20. doi: 10.1517/14656566.2014.954549. Epub 2014 Aug 25.

PMID:
25154562
12.

Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).

Sato M, Ohmori-Matsuda K, Saito T, Matsuda Y, Hwang DM, Waddell TK, Singer LG, Keshavjee S.

J Heart Lung Transplant. 2013 May;32(5):484-91. doi: 10.1016/j.healun.2013.01.1054. Epub 2013 Feb 22.

PMID:
23433813
13.

Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes.

Saito T, Takahashi H, Kaneda H, Binnie M, Azad S, Sato M, Waddell TK, Cypel M, Liu M, Keshavjee S.

Am J Transplant. 2013 Dec;13(12):3192-201. doi: 10.1111/ajt.12492. Epub 2013 Oct 24.

14.

Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.

Luckraz H, Sharples L, McNeil K, Wreghitt T, Wallwork J.

J Heart Lung Transplant. 2003 Mar;22(3):287-91.

PMID:
12633696
15.

Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?

Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA.

Ann Thorac Surg. 2006 Jan;81(1):286-91; discussion 291.

PMID:
16368382
16.

Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey.

Kapila A, Baz MA, Valentine VG, Bhorade SM; AIRSAC investigators.

J Heart Lung Transplant. 2015 Jan;34(1):65-74. doi: 10.1016/j.healun.2014.09.029. Epub 2014 Oct 7.

PMID:
25447585
17.

Small bowel transplant: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2003;3(1):1-72. Epub 2003 Apr 1.

18.

Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.

Valentine VG, Gupta MR, Walker JE Jr, Seoane L, Bonvillain RW, Lombard GA, Weill D, Dhillon GS.

J Heart Lung Transplant. 2009 Feb;28(2):163-9. doi: 10.1016/j.healun.2008.11.907.

PMID:
19201342
19.

Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS).

Fisher AJ, Wardle J, Dark JH, Corris PA.

J Heart Lung Transplant. 2002 Nov;21(11):1206-12.

PMID:
12431494
20.

Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.

Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J.

J Heart Lung Transplant. 1998 Dec;17(12):1255-63.

PMID:
9883768
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk